What is trazodone used for? Mainly to take the edge off a specific, time-limited event: a thunderstorm, a car journey, a veterinary appointment, the first fortnight after surgery when the dog must stay quiet. It is not a tranquilliser in the sense most owners mean, and it is not a cure for an anxiety disorder. It is a serotonin antagonist and reuptake inhibitor that changes how much serotonin stays in the gaps between nerve cells for a few hours, and the practical consequences of that are narrower than the internet suggests.
The narrowness is the point. This is a drug that works well when it is matched to a defined event with a defined start and end, and works badly when it is used to paper over a problem that needs a behaviour plan, a pain investigation or a change in the environment. The four things an owner needs to know before the first tablet are what it is for, how long it lasts, what it interacts with, and what would make it the wrong choice for this particular animal.
It belongs to a class called serotonin antagonist and reuptake inhibitors, usually shortened to SARI. The mechanism is dual: it blocks two serotonin receptor subtypes, and it weakly blocks the transporter that clears serotonin from the synapse.
The receptor blockade is the part that matters at the doses used in animals. Blocking those receptors dampens the circuits involved in arousal and agitation, and there is also antagonism at histamine and alpha-adrenergic receptors, which is where a good deal of the sedation comes from. The reuptake inhibition that gives the drug its antidepressant reputation in human psychiatry happens at doses far higher than the ones used for a dog before a fireworks display, and that gap is why the drug can calm an animal without drugging it into stillness.
It is worth understanding that "calm" and "sedated" are not the same outcome, because owners often expect the second and are disappointed by the first. A dog on a working dose of trazodone is usually still able to walk, eat and respond to its name. What it is less able to do is escalate. That distinction decides whether the drug is helping or merely suppressing.
In animals, the drug is used extra-label, meaning no manufacturer has taken it through the licensing process for dogs or cats. In practice it does two jobs.
The first is situational: a known stressor with a known window. Storms, fireworks, a flight, a house move, a first day at a new house, a veterinary procedure. The drug is given before the event, its effect covers the event, and it wears off afterwards.
The second is adjunctive: an animal already on a behaviour modification plan, where the drug lowers the arousal enough for the training to be learnable. It is not given instead of the plan. It is given so that the plan has a chance.
Everything else on the internet — treating separation anxiety, managing aggression, quietening a boisterous adolescent, helping a dog settle in a new home permanently — is an extension of those two jobs, and the extension only works if the second job is done properly. A dog that is sedated but still exposed to the thing it fears learns nothing except that the fear is inescapable.
The commonest legitimate use is a dog that is fine for three hundred and sixty days a year and falls apart on the remaining five.
Veterinary visits are the textbook case. A dog that becomes unhandleable in the consulting room cannot be examined properly, which means the examination is shorter and less informative than it should be, which means the diagnosis is worse. A pre-visit dose that takes the panic down two notches produces a better consultation and, over several visits, a dog that is less afraid of the building. That is a clinical gain, not a convenience.
The same logic applies to grooming, nail trims and travel. In each case the drug is not removing the fear; it is lowering it enough that the animal can stay in the room and accumulate a different experience of the room.
This is where owners most often get the timing wrong. A tablet given as the car pulls into the clinic car park has not had time to work, and the animal has a full panic episode plus a drug that arrives late. The trial run described further down exists to prevent exactly that.
Fireworks and thunderstorms are the other classic indication, and they expose a weakness in the whole approach.
Noise phobia escalates with exposure. A dog that panics at every thunderstorm through a summer usually panics harder the following summer, because each event adds to the association rather than extinguishing it. Medication that prevents a full panic episode interrupts that ratchet, which is why the timing rules matter more than the drug choice.
The drug needs to be on board before the noise starts, which means giving it when the forecast says the storm arrives in an hour, not when the first crack of thunder lands. It also means a second dose may be needed if the event runs long, which is a conversation to have with the prescribing vet in advance rather than at midnight.
There is a limit here that owners should hear plainly. A dog with a severe noise phobia needs a behaviour plan with desensitisation and counter-conditioning, proper sound recordings at controlled volumes, and often a different drug regime for the peak season. Trazodone given on the night is a fire blanket, not a fire plan.
The most underrated use is the dog that has had an operation and must not move.
A young retriever with a repaired cruciate ligament is a genuine clinical problem, because the surgery fails if the dog jumps, runs or spins. Sedation in that situation is not a luxury; it is part of the treatment, on the same level as the suture pattern.
Trazodone is used here for its combination of calm without complete immobilisation. The dog can still toilet, eat and shift position, which matters for recovery, but is less likely to explode off the sofa. In practice it is often combined with other medication, and the combination is decided by the surgeon.
The mistake in this category is treating the drug as a substitute for environmental control. A sedated dog in an unfenced garden will still try to follow a cat. Crates, gates, ramps and short lead walks do the structural work; the tablet only lowers the probability of a leap.
Car anxiety splits into two groups that owners routinely confuse, and the drug only helps one of them.
The first is genuine fear: trembling, drooling, vomiting, defecation, and a dog that starts to resist getting into the car at all. That is a fear response and it responds to a pre-travel dose plus a gradual retraining programme with short, non-eventful journeys.
The second is motion sickness with no fear component. The dog is fine in the car until its stomach turns over, and the problem is vestibular rather than emotional. Trazodone does not fix a vestibular problem, and giving it may simply add sedation to nausea. If the dog is sick before it starts to look frightened, the conversation is about anti-nausea medication and travel management, not about anxiety drugs.
Long journeys are the case where a trial run is almost mandatory. A dog that becomes ataxic at altitude on a motorway is a worse problem than a dog that trembles at home.
Cats are treated with the same drug for shorter, sharper indications: a veterinary visit, a car journey, a move, a period of cage rest.
The pharmacology is broadly similar, but the practical differences matter. Cats are harder to dose by tablet, more prone to hiding distress rather than showing it, and more sensitive to the sedation-hypotension combination. Peak effect tends to arrive later, so a morning appointment needs the tablet given further ahead than a dog would.
Cats also have a specific risk profile around handling: a cat that is sedated but still frightened may be easier to examine and harder to read, because the behavioural signals flatten. That is a reason for the examining vet to know the drug was given, not a reason to skip it.
It does not treat pain. A dog that is restless, pacing and unable to settle at night may be in pain, and sedation in that situation removes the signal without removing the cause.
It does not fix a fear of strangers, other dogs or the vacuum cleaner. Those need structured exposure, and a drug that lowers arousal can help the exposure work, but on its own it produces a calm dog that is still afraid.
It does not replace a diagnosis. Sudden-onset anxiety in an older dog, new night waking, new clinginess, or a first-ever noise sensitivity are all reasons to look for a medical cause — pain, thyroid disease, cognitive change, sensory loss — before reaching for a behaviour drug.
And it does not make a dog safe to handle if the underlying problem is aggression rooted in fear. A disinhibited dog is not necessarily a safer dog, and the combination of sedation and fear can produce a bite with less warning than usual.
There is a reasonable objection here: if the drug works, why does anything else need to change?
Because the drug is temporary and the learning is not. Every exposure to a feared thing while the animal is calm is a data point for the animal's nervous system; every exposure while panicking is a data point in the other direction. The drug is useful to the extent that it changes which kind of data point is being laid down.
That is also why the drug is often paired with a training plan that includes very small, controlled exposures, a predictable routine, and a way for the animal to leave the situation. The tablet lowers the starting arousal; the plan teaches the animal what to do instead.
A household that medicates and changes nothing else usually reports the same thing after a few months: the drug works less well than it did, and the dose keeps climbing. That is not tolerance in the pharmacological sense so much as the underlying problem having grown.
The drug takes effect within roughly one to two hours for short-term stress relief, and the effect usually clears within a day. Long-term behavioural use is different: full effect on the anxiety itself can take a few weeks of consistent dosing.
That short window is what makes the trial run essential. Pick a quiet day, give the dose the vet prescribed, and watch the dog for six hours. Note the time to first change, the depth of sedation, whether the dog can walk steadily, whether it eats, and when it returns to normal. That record is far more useful to the vet than a description of "it seemed sleepy".
The trial matters because the response range is wide. Some dogs are barely affected at a dose that leaves another dog flat for six hours. Some become paradoxically more anxious, which is uncommon but well described and is a reason to stop and call rather than to push through.
The common ones are sedation, drowsiness, a wobbly gait, dilated pupils, and sometimes increased appetite.
Vomiting and loose stool occur, and giving the tablet with food reduces the nausea. Some dogs salivate heavily or gag at the tablet itself rather than reacting to the drug.
A small proportion become more anxious rather than less, and a smaller proportion show irritability or a snap that is out of character. Both are reasons to stop and speak to the prescriber before the next event.
In the published veterinary experience, the great majority of dogs have no meaningful side effects, which is why the drug is used as widely as it is. That statistic is reassuring for a population and not a guarantee for an individual, which is the whole argument for a trial.
A short list deserves its own heading, because these are the ones that change the plan rather than the timing.
Persistent and painful erection is a recognised adverse effect of this class of drug in dogs. It is uncommon, it is a medical matter rather than a wait-and-see, and it needs veterinary attention.
Heart rhythm changes have been reported. A dog with an existing arrhythmia, or one that faints or collapses, needs that investigated before any behaviour drug is added.
Serious neurological signs — tremors, rigidity, hyperthermia, disorientation — point at serotonin excess rather than at ordinary sedation, and they are an emergency.
Vomiting that will not stop, a dog that cannot stand, or a dog that becomes unresponsive are all reasons to stop giving the drug and seek help the same day.
This is the risk that matters most, and it is almost entirely about what else the animal is taking.
Serotonin syndrome happens when serotonergic signalling exceeds what the body can handle. The signs include agitation or tremor, increased heart rate, raised body temperature, dilated pupils, diarrhoea, disorientation, and in severe cases seizures. It can progress quickly, and it is treatable when it is recognised early.
The combinations that raise the risk are well documented. Monoamine oxidase inhibitors are the clearest contraindication. Selective serotonin reuptake inhibitors and tricyclic antidepressants raise the risk and are sometimes still used together under close veterinary supervision, because the combination has real benefit in behaviour medicine — but that decision belongs to the prescriber, not to an owner adding a tablet from an old packet.
Tramadol, metoclopramide and other serotonergic drugs add to the risk. So do some non-drug products, which is the next section.
There is one interaction that catches owners out because the product does not look like a medicine: amitraz.
Amitraz is an antiparasitic used in some tick collars, spot-ons and washes, and it has monoamine oxidase inhibitor activity. Combined with trazodone, it raises the risk of serotonin excess. Owners routinely forget to mention a collar because a collar does not feel like a drug, and vets routinely ask about medication but not always about parasite products.
The practical rule is simple: before the first dose, list everything the animal is wearing, everything it is given, and every supplement in the cupboard, including the herbal ones. Then keep that list updated, because a collar bought in spring may still be on in summer when a thunderstorm prescription arrives.
The contraindications are short and worth knowing in full, because they are the questions a pharmacist or vet will ask.
Animals with a known hypersensitivity to the drug should not receive it. Animals currently on a monoamine oxidase inhibitor should not receive it. Animals with angle-closure glaucoma should not receive it, because the drug's anticholinergic activity can raise intraocular pressure.
It should be used with caution, not necessarily avoided, in animals with severe heart disease, in animals with liver or kidney impairment, and in pregnant or breeding animals, where the data are thin and the decision is a balancing exercise.
Some veterinary references go further and say the drug should not be used at all in heart failure, liver failure or kidney failure. Where sources differ like this, the practical answer is that the prescriber decides after examining the animal, and the owner's job is to make sure the prescriber knows about the murmur, the blood results, or the fact that the animal is a breeding queen.
The claim that the drug stops working within a day is true for a healthy animal and less true for one with impaired clearance.
The liver metabolises it and the kidneys clear the metabolites, so an animal with hepatic or renal disease can have a longer, deeper effect than expected. That changes the timing advice: a dog with kidney disease may still be sedated the following morning, which matters if the dog is going to be left alone or needs to navigate stairs.
It also changes the trial run. For an animal with any organ impairment, the first dose should be given on a day when someone can watch for the full day, and the vet should be told what was observed before the second dose is planned.
Alpha-adrenergic blockade lowers blood pressure, which is usually minor and occasionally not.
The dogs at higher risk are those already on antihypertensive medication, those with a cardiac condition that depends on vascular tone, and those that are dehydrated or in shock. The combination with other sedatives can compound the drop.
For an owner, the practical signs are weakness on standing, a wobbly walk that does not resolve, pale gums, or a dog that seems to fade rather than settle. Any of those is a reason to stop, keep the dog warm and call.
The data in pregnant animals are limited, and animal studies at very high doses have shown adverse effects on the developing fetus. That does not make a single pre-travel dose dangerous, but it does mean the decision belongs to a vet who knows the stage of pregnancy and the alternatives.
For breeding animals the same caution applies in a different form: the drug affects serotonin and vascular tone, and neither has been studied in enough pregnant queens or bitches to make confident claims.
The honest position is that this is a gap, not a known safety. Owners planning a litter should raise it before a behaviour drug is prescribed, not after.
Doses for this drug vary by indication, by species, by weight, by concurrent medication and by the animal's organ function, and they are set by a veterinarian who has examined the animal.
Publishing a number here would invite an owner to calculate a dose from a tablet strength designed for a person, and the arithmetic errors in that exercise are the ones that cause poisonings. PawAtlas keeps the line in the same place every time: the number belongs to the vet who examined the animal, and the observation belongs to the owner. Tablet sizes for human use do not map onto animal weights, and the common assumption that half a tablet is half the effect is wrong for a drug with a wide response range.
What is useful to know is the shape of the decision: a low starting dose, an observed trial, a step up only after the response is recorded, and a maximum that the prescriber sets. An owner who understands that shape can have a better conversation with the vet than one who arrives with a number from a forum.
The drug can be given with or without food, and giving it with a small amount of food reduces nausea in animals that vomit on an empty stomach.
The common failure is the dog that finds the tablet in the cheese. A dog that is already anxious is not a dog to negotiate with at the last minute, so the delivery method should be tested on an ordinary day, not on the morning of the appointment.
For cats, the practical options are a pill pocket, a compounded liquid if the prescriber arranges it, or a small amount of a strong-tasting food. A cat that has been dosed by force and then handled at the clinic has two stressors stacked on top of each other, which is the opposite of the goal.
If the animal spits the tablet out, do not give a second full dose on the assumption that nothing was absorbed. Call and ask, because part of a dose plus a second dose is a common route to oversedation.
For situational use the rule is straightforward: if the dose is missed, give it when remembered if there is still time for it to work, and skip it if the event has passed.
For daily behavioural use, a missed dose is given as soon as it is remembered unless the next one is close, in which case it is skipped. Doubling up to catch up is the thing not to do, because the effect is dose-dependent and the side effects are too.
A double dose produces deep sedation, wobbliness, and sometimes vomiting. The response is to keep the animal warm, restrict access to stairs and water hazards, and call the vet or the poisons service for advice rather than waiting to see.
The drug should be kept at room temperature, in an airtight container, protected from light. That is not fussiness: light and moisture degrade it, and a tablet that has lived in a hot car for a month is not the tablet that was prescribed.
The other storage problem is human medication. Extended-release tablets made for people are not equivalent to the immediate-release tablets used in animals, and substituting one for the other changes the whole time profile. If the household has both, they should not be in the same drawer.
Tablets should also be counted. A dog that finds an open bottle is a poisoning case, and the clinical picture after a large ingestion is different from the picture after a prescribed dose.
A short record turns a vague impression into something a vet can act on, and it takes five minutes.
Note the time of the dose, the time of the first visible change, the time of peak effect, and the time the animal was back to normal. Note whether the gait was steady at peak, whether the animal ate, whether it toileted normally, and whether the pupils were dilated. Note anything unexpected, especially increased anxiety, vocalisation, or a stiffness that was not there before.
Bring that record to the next appointment. A vet who can see that the effect peaked at ninety minutes and cleared by six hours can plan the next event far better than one told that the dog "seemed fine".
Call the prescriber before the next dose if the animal was more anxious rather than less, if the sedation was deeper than expected, if the animal vomited repeatedly, or if there was any stiffness, tremor or unusual vocalisation.
Go in the same day if there is persistent painful erection, a seizure, a temperature that feels high to the touch combined with agitation, a dog that cannot stand, a cat that is breathing fast and open-mouthed, or any sign that suggests the animal took more than the prescribed amount.
The general principle is that this drug is safe for most animals at prescribed doses and unforgiving in two situations: when it is combined with another serotonergic drug, and when the amount taken is unknown. Both of those are conversations to have immediately rather than to monitor at home.
Both descriptions are partly right and both mislead. In animals it is used mainly for its calming and arousal-lowering effect, which is closer to a sedative with anxiolytic properties. The antidepressant action in people happens at much higher doses and is not the reason it is prescribed for a dog before a thunderstorm.
Usually one to two hours, but the number matters less than the trial. Give it once on a quiet day, record when the effect appears, and use that timing for the real event.
It can be used daily under supervision for a defined period, and it is used that way in behaviour medicine. Daily use without a plan, a review date and a way of measuring progress is the pattern that produces a dog on medication indefinitely with no change in the underlying problem.
Most dogs are calmer rather than unconscious, and the drug is short-acting by design. A dog that is still flat the next morning at a prescribed dose is a dog whose response should be reported before anything else is given.
Ask first. Some tick products contain amitraz, which has monoamine oxidase inhibitor activity, and that combination raises the risk of serotonin excess. The collar counts as a drug for this purpose.
That combination is used in behaviour practice, but it is a decision for the prescriber, with monitoring, because the risk of serotonin excess is higher. Do not add one to the other without telling the vet who prescribed the first.
It may be, and the decision depends on the kind of murmur and the animal's blood pressure. Alpha blockade lowers blood pressure, so a dog with significant cardiac disease needs that assessed rather than assumed.
Yes, extra-label, mainly for short events such as a veterinary visit or travel. Cats reach peak effect on a slower clock, so the tablet goes down earlier in the day than it would for a dog.